The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 07, 2021

Filed:

Aug. 15, 2018
Applicant:

Adaptimmune Limited, Abingdon, GB;

Inventors:

Garth Hamilton, Abingdon, GB;

Jonathan Silk, Abingdon, GB;

Claire Gueguen, Abingdon, GB;

Assignee:

Adaptimmune Ltd, Oxfordshire, GB;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 35/00 (2006.01); C07K 14/725 (2006.01); C07K 14/47 (2006.01); A61K 39/00 (2006.01); C07K 16/30 (2006.01); C07K 14/54 (2006.01); C07K 16/24 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
C07K 16/2833 (2013.01); A61K 39/0011 (2013.01); A61P 35/00 (2018.01); C07K 14/4748 (2013.01); C07K 14/5418 (2013.01); C07K 14/7051 (2013.01); C07K 16/244 (2013.01); C07K 16/30 (2013.01); C12N 5/0636 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/5158 (2013.01); C07K 2317/622 (2013.01); C07K 2319/03 (2013.01); C07K 2319/33 (2013.01);
Abstract

This invention relates to modified T cells that inducibly express a bioactive molecule, such as IL-7, and constitutively expresses an antigen receptor, such as a T cell receptor or chimeric antigen receptor that binds to a tumour antigen. The modified T cells may comprise a nucleic acid construct that comprises a first nucleotide sequence encoding the bioactive molecule, a second nucleotide sequence encoding the antigen receptor; an inducible promoter operably linked to the first nucleotide sequence and a constitutive promoter operably linked to the second nucleotide. Nucleic acid constructs and vectors are provided, as well as T cells comprising such constructs and vectors and therapeutic methods and uses thereof.


Find Patent Forward Citations

Loading…